III
GILD icon

Independent Investors Inc’s Gilead Sciences GILD Stock Holding History

Independent Investors Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,600
Closed -$489K – 90
2014
Q3 		$489K Hold
4,600
– – 0.22% 73
2014
Q2 		$381K Buy
4,600
+300
+7% +$23.4K 0.17% 79
2014
Q1 		$304K Buy
+4,300
New +$337K 0.15% 83

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Independent Investors Inc's GILD Position: Q4 2014 in Review

Independent Investors Inc sold out of Gilead Sciences (GILD) in Q4 2014, closing a stake of 4,600 shares — an estimated $489K sold.

Independent Investors Inc first reported a position in GILD in Q1 2014 and held it in 3 quarters. The position peaked at $489K in Q3 2014. 1,439 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Independent Investors Inc reported no remaining Gilead Sciences position as of Q4 2014 after selling out during the quarter.
  • Independent Investors Inc sold 4,600 Gilead Sciences shares in Q4 2014, an estimated $489K.
  • Independent Investors Inc first reported a position in Gilead Sciences in Q1 2014 and held it in 3 quarters.
  • Independent Investors Inc's Gilead Sciences position peaked at $489K in Q3 2014.
  • 1,439 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Independent Investors Inc's 13F filing for Q4 2014, filed 6 Feb 2015.